"Our (sales) guidance includes the impact of the planned exit from private label pet nutrition over the course of 2025," said ...
Shares of Colgate-Palmolive ( NYSE: CL) are trading defensively ahead of Friday’s opening bell as mixed fourth quarter ...
Colgate-Palmolive Co. (CL) revealed earnings for its fourth quarter that increased from the same period last year and beat the ...
Colgate Palmolive is looking at ways to reduce the impact of possible tariffs on its toothpastes, which the company ...
Buying Colgate-Palmolive Company shares after their 20% drop may not be a good idea for dividend or total return investors.
Goldman Sachs analyst Bonnie Herzog maintains a Buy rating on Colgate-Palmolive, with a price target of $106. Despite Q4 EPS of $0.91 exceeding expectations, organic sales growth of 4.3% fell short.
Colgate-Palmolive forecast 2025 sales to be roughly flat from last year; sales came in at $20.10 billion in 2024. Write to Denny Jacob at [email protected] ...
Colgate-Palmolive Co. said it’s preparing for potential tariffs that could impact toothpaste sold in the US that comes from ...
Colgate-Palmolive reported a slight decline in Q4 sales, dropping 0.12% to $4.94 billion, missing estimates. However, organic ...
The company's net sales in Latin America, a major revenue contributing region, fell 7.2 per cent and dropped 1 per cent in ...